Find the Best in Gaithersburg

FDA panel deals blow to maintenance therapy with Tarceva (CancerFacts.com)

GAITHERSBURG, Md.– Dec. 16, 2009 – An FDA panel today put the brakes on a drug strategy that aims to prolong cancer-free and overall survival among non-small cell lung cancer patients by using Tarceva® (erlotinib) as a maintenance therapy.

See original here:
FDA panel deals blow to maintenance therapy with Tarceva (CancerFacts.com)

Comments

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!